Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13
Diagnostic Center
Diagnostic Center | 28 July 2022

Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate

This next-generation bivalent COVID-19 vaccine candidate, BNT162b5, consists of RNAs encoding enhanced prefusion spike proteins for the SARS-CoV-2 ancestral strain (wild-type) and an Omicron variant.

Diagnostic Center
Diagnostic Center | 27 July 2022

Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study

The NTM-001 Phase I clinical study is expected to be completed by the end of 2022

Diagnostic Center
Diagnostic Center | 26 July 2022

Krsnaa Diagnostics bags large tender in Maharashtra

The tenure of contract will be upto 10 years from date of signing the contract/installation.

Diagnostic Center
Diagnostic Center | 24 July 2022

Merck opens microbiology application lab in Jigani, Bengaluru

Merck’s first microbiology application and training lab in India

Diagnostic Center
Diagnostic Center | 19 July 2022

Lupin Diagnostics launches its first reference laboratory in Ranchi

Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies

Diagnostic Center
Diagnostic Center | 14 July 2022

Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray

The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.

Diagnostic Center
Diagnostic Center | 13 July 2022

SRL Diagnostics launches fatty liver index

An algorithm based testing for Fatty Liver Disease

Diagnostic Center
Diagnostic Center | 04 July 2022

Clinical study of PD-L1 antibody ASC22 for cure of HIV completes first patient dosing

Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection

Diagnostic Center
Diagnostic Center | 21 June 2022

Parexel expands patient access to clinical trials through new community alliance network

Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials

Diagnostic Center
Diagnostic Center | 16 June 2022

Lupin Diagnostics launches its first regional reference lab in Patna

Expanding diagnostics footprint in East India

Diagnostic Center
Diagnostic Center | 14 June 2022

Philips announces positive research results from its TOBA II BTK clinical trial

First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization

Diagnostic Center
Diagnostic Center | 12 June 2022

Amytrx Therapeutic's AMTX-100 CF3 moves to phase II clinical trial for atopic dermatitis

Amarex Clinical Research guides its client to phase II of FDA trials

Diagnostic Center
Diagnostic Center | 11 June 2022

Takeda’s dengue vaccine candidate offers protection against dengue fever in clinical trial

TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union

Diagnostic Center
Diagnostic Center | 11 June 2022

Sanyou Biopharmaceuticals launches Super-Trillion Antibody Libraries

New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets

Diagnostic Center
Diagnostic Center | 10 June 2022

Marinus expands enrollment criteria to support recruitment in Phase 3 RAISE Trial in refractory status epilepticus

Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.

Diagnostic Center
Diagnostic Center | 08 June 2022

CerTest Biotec and BD collaborates for molecular diagnostic test for Monkeypox

CerTest Biotec uses the BD MAX molecular diagnostic system open system reagent suite to develop RT-PCR detection kit

Diagnostic Center
Diagnostic Center | 08 June 2022

Novartis Scemblix shows better result for chronic myeloid leukemia trial

Scemblix (asciminib) continues to show superior efficacy with more-than-two-fold improvement in major molecular response rate vs. Bosulif (bosutinib) at 96 weeks

Diagnostic Center
Diagnostic Center | 25 May 2022

Thyrocare launches its Regional Processing Lab in Nagpur on World Thyroid Day

The new advanced regional processing lab will serve Nagpur city and the Vidarbha region

Diagnostic Center
Diagnostic Center | 20 May 2022

Motilal Oswal Private Equity (MOPE) invests in Pathkind Diagnostics

A primary investment of Rs 194.4 crore has been made

Diagnostic Center
Diagnostic Center | 10 May 2022

Cipla launches ‘RT Direct’ Multiplex real-time PCR kit for Covid-19

RNA extraction free kit to deliver results in just 45 minutes

Startup

Digitization